ConductScience.org, home

Paper36979827

Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model.

Ignacio-Mejía I and 11 others. Biomedicines, 2023. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model. Papers, record 36979827. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979827

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model.
PubMed
Journal
Biomedicines
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.63
iCite
Revised in PubMed
2023-03-31
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ignacio-Mejía IIvánhttps://orcid.org/0000-0003-3792-4613
2Contreras-García IJItzel Jatziri
3Mendoza-Torreblanca JGJulieta Griseldahttps://orcid.org/0000-0003-0702-5318
4Medina-Campos ONOmar Noelhttps://orcid.org/0000-0001-8264-0412
5Pedraza-Chaverri JJoséhttps://orcid.org/0000-0001-6628-4411
6García-Cruz MEMercedes Edna
7Romo-Mancillas AAntoniohttps://orcid.org/0000-0003-2869-588X
8Gómez-Manzo SSaúlhttps://orcid.org/0000-0003-2095-9182
9Bandala CCindy
10Sánchez-Mendoza MEMaría Elena
11Pichardo-Macías LALuz Adriana
12Cárdenas-Rodríguez NNoemíhttps://orcid.org/0000-0002-6580-3440

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2022/048E022 Program of the Instituto Nacional de PediatríaPubMed
A1-S-17090Fondo Sectorial de Investigación, CONACyTPubMed
20221351Instituto Politécnico NacionalPubMed

Source PubMed

Download CSV of grants

References80

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130037344Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy.J Neuroinflammation2018https://conductscience.org/library/papers/30037344PubMed
28660627The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay.Anal Biochem1996https://conductscience.org/library/papers/8660627PubMed
329124680The Antiepileptic Drug Levetiracetam Protects Against Quinolinic Acid-Induced Toxicity in the Rat Striatum.Neurotox Res2018https://conductscience.org/library/papers/29124680PubMed
429596151A novel online fluorescence method for in-vivo measurement of hydrogen peroxide during oxidative stress produced in a temporal lobe epilepsy model.Neuroreport2018https://conductscience.org/library/papers/29596151PubMed
531356760Effects of Three Anti-Seizure Drugs on Cholinergic and Metabolic Activity in Experimental Status Epilepticus.J Pharm Pharm Sci2019https://conductscience.org/library/papers/31356760PubMed
635916986An aqueous extract of Syzygium cumini protects against kainate-induced status epilepticus and amnesia: evidence for antioxidant and anti-inflammatory intervention.Metab Brain Dis2022https://conductscience.org/library/papers/35916986PubMed
722895709Post-translational oxidative modification and inactivation of mitochondrial complex I in epileptogenesis.J Neurosci2012https://conductscience.org/library/papers/22895709PubMed
836459714Specific inhibition of NADPH oxidase 2 modifies chronic epilepsy.Redox Biol2022https://conductscience.org/library/papers/36459714PubMed
926440581Totarol prevents neuronal injury in vitro and ameliorates brain ischemic stroke: Potential roles of Akt activation and HO-1 induction.Toxicol Appl Pharmacol2015https://conductscience.org/library/papers/26440581PubMed
1036600279Nrf2 is predominantly expressed in hippocampal neurons in a rat model of temporal lobe epilepsy.Cell Biosci2023https://conductscience.org/library/papers/36600279PubMed
1127698937Activation of GLP-1 Receptor Enhances Neuronal Base Excision Repair via PI3K-AKT-Induced Expression of Apurinic/Apyrimidinic Endonuclease 1.Theranostics2016https://conductscience.org/library/papers/27698937PubMed
1229024726The antiepileptic drug levetiracetam promotes neuroblast differentiation and expression of superoxide dismutase in the mouse hippocampal dentate gyrus via PI3K/Akt signalling.Neurosci Lett2018https://conductscience.org/library/papers/29024726PubMed
1320136375Levetiracetam: a comprehensive review.Expert Rev Neurother2010https://conductscience.org/library/papers/20136375PubMed
1430622673Effects of Valproate Monotherapy on the Oxidant-Antioxidant Status in Mexican Epileptic Children: A Longitudinal Study.Oxid Med Cell Longev2018https://conductscience.org/library/papers/30622673PubMed
1523137652Advantages and limitations of brain imaging methods in the research of absence epilepsy in humans and animal models.J Neurosci Methods2013https://conductscience.org/library/papers/23137652PubMed
1630026766Serum Total Antioxidant Capacity of Epileptic Children before and after Monotherapy with Sodium Valproate, Carbamazepine, and Phenobarbital.Iran J Child Neurol2018https://conductscience.org/library/papers/30026766PubMed
1732430101Neuroprotective and anticonvulsant effects of sinomenine in kainate rat model of temporal lobe epilepsy: Involvement of oxidative stress, inflammation and pyroptosis.J Chem Neuroanat2020https://conductscience.org/library/papers/32430101PubMed
1833149593LncRNA MEG3 Reduces Hippocampal Neuron Apoptosis via the PI3K/AKT/mTOR Pathway in a Rat Model of Temporal Lobe Epilepsy.Neuropsychiatr Dis Treat2020https://conductscience.org/library/papers/33149593PubMed
1932088583The global burden of epilepsy report: Implications for low- and middle-income countries.Epilepsy Behav2020https://conductscience.org/library/papers/32088583PubMed
2031302262Protective Role of Levetiracetam Against Cognitive Impairment And Brain White Matter Damage in Mouse prolonged Cerebral Hypoperfusion.Neuroscience2019https://conductscience.org/library/papers/31302262PubMed

See all 80 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42794835Levetiracetam and Peripheral Oxidative Stress Biomarkers in Epilepsy: A Systematic Review of Human Evidence.Int J Mol Sci2026https://conductscience.org/library/papers/42794835PubMed
42589265Anti-Inflammatory and Antioxidant Strategies in Epilepsy: From Molecular Mechanisms to Threshold Management.Int J Mol Sci2026https://conductscience.org/library/papers/42589265PubMed
42571206Suspected levetiracetam drug-induced lupus in a child: A case report.SAGE Open Med Case Rep2026https://conductscience.org/library/papers/42571206PubMed
40217882MicroRNAs as Epigenetic Biomarkers of Pathogenetic Mechanisms of the Metabolic Syndrome Induced by Antiseizure Medications: Systematic Review.J Clin Med2025https://conductscience.org/library/papers/40217882PubMed
39996118
Mimosa pudica L. aqueous extract protects mice against pilocarpine-picrotoxin kindling-induced temporal lobe epilepsy, oxidative stress, and alteration in GABAergic/cholinergic pathways and BDNF expression.
Front Pharmacol2024https://conductscience.org/library/papers/39996118PubMed
39695322Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis.Mol Psychiatry2025https://conductscience.org/library/papers/39695322PubMed
3933475210-Gingerol Increases Antioxidant Enzymes and Attenuates Lipopolysaccharide-Induced Inflammation by Modulating Adipokines in 3T3-L1 Adipocytes.Antioxidants (Basel)2024https://conductscience.org/library/papers/39334752PubMed
39273262Effect of Levetiracetam on Oxidant-Antioxidant Activity during Long-Term Temporal Lobe Epilepsy in Rats.Int J Mol Sci2024https://conductscience.org/library/papers/39273262PubMed
38530519
Therapeutic Effect of Levetiracetam Against Thioacetamide-Induced Hepatic Encephalopathy Through Inhibition of Oxidative Stress and Downregulation of NF-κB, NLRP3, iNOS/NO, Pro-Inflammatory Cytokines and Apoptosis.
Inflammation2024https://conductscience.org/library/papers/38530519PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CAT847PubTator's text mininghttps://conductscience.org/library/genes/847NCBI Gene
GSR2936PubTator's text mininghttps://conductscience.org/library/genes/2936NCBI Gene
SOD16647PubTator's text mininghttps://conductscience.org/library/genes/6647NCBI Gene
SV2A9900PubTator's text mininghttps://conductscience.org/library/genes/9900NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36979827

GET https://conductscience.org/api/papers/v1/36979827/references?page=2